Comvita Limited · NZX:CVT
Comvita — Investor Presentation (May 2016)
11 slides from Comvita's investor presentation, May 2016
Slide 1: Investor Presentation May 2016
INVESTOR PRESENTATION MAY 2016 C HAIRMAN , N EIL C RAIG, 021 731 509 C HIEF EXEC UT IVE OFFIC ER, S C OT T C OULT ER, 021 386 988 C HIEF FIN AN C IAL OFFIC ER, MARK S ADD, 027 707 9698
Slide 2: Important Notice
Investor Presentation May 2016 Pg.1 IMPORTANT NOTICE This presentation is given on behalf of Comvita Limited. Information in this presentation: ● Should be read in conjunction with, and is subject to, Comvita’s latest and prior Annual Reports, Interim Reports and market releases on NZX; ● Is from un
Slide 3: Comvita achieves record result
Investor Presentation May 2016 Pg.2 “Comvita achieves record result*. An unaudited, after tax profit of $17.2 million on sales of $202 million.” *For the 12 month period ending 31 March 2016
Slide 4: Key Achievements
Investor Presentation May 2016 Pg.3 KEY ACHIEVEMENTS $202m 68% 50:50 2 1 32% increase Increase in Joint venture with Peer reviewed, Focus compared NPAT Capilano Honey Pty published, clinical on to FY2015 compared Ltd to grow medical research studies on Innovation to FY2015 honey supply Olive Leaf Ex
Slide 5: Sales growth by region
Investor Presentation May 2016 Pg.4 EUROPE -6% sales growth MEDICAL 58% sales growth -$0.6m $3.4m ASIA 38% sales growth $18.0m S A L E S G RO W T H AUSTRAL IA TO 62% sales growth M A RC H 2 0 1 6 $24.7m NZ -0% sales growth -$0.2m Figures are based on 12 months unaudited results to 31 March 2016.
Slide 6: Market Segments
Investor Presentation May 2016 Pg.5 24% 67% 3% 6% OF TOTAL REVENUE OF TOTAL REVENUE OF TOTAL REVENUE OF TOTAL REVENUE M A RK E T HEALTHC ARE FUNC TIONAL FOODS PERSONAL C ARE MEDIC AL SE G ME NTS 11% GROWTH 12 MONTHS 38% GROWTH 12 MONTHS 44% GROWTH 12 MONTHS 91% GROWTH 12 MONTHS Figures are based on
Slide 7: Key Financial Highlights
Investor Presentation May 2016 Pg.6 2016 2015 Financial results for the Change $’000 $’000 12 months to 31 March % Unaudited Audited Revenue 202,155 152,702 32% EBITDA* 36,416 22,950 59% EBITDA % of operating revenue 18.0% 15.0% 3% Net profit after tax 17,204 10,244 68% KEY FINANCIAL Earnings per sh
Slide 8: Financial Performance
2009 $71m 2010 $85m 2011 $82m 2012 $96m 2013 $103m G ROUP RE VE NUE Investor Presentation May 2016 2014 $115m 2015 $153m 2016 U NAU DITED $202m 2009 $5.3m 2010 * EBITDA – Earnings before interest, tax, depreciation and amortisation. $11.2m E BI TDA * 2011 $6.3m 2012 $15.5m 2013 $14.7m 2014 $17.0m 20
Slide 9: Key Balance Sheet Ratios
Investor Presentation May 2016 Pg.8 2016 2015 Key Balance Sheet Ratios Change $’000 $’000 as at 31 march % Unaudited Audited Total assets 231,563 199,722 16% Raw material inventory 53,648 27,722 94% Net debt 58,692 26,093 125% KEY BALANCE Net debt to equity ratio 45.4% 22.0% 23% SH E E T RA T I O S
Slide 10: Net Debt and Gearing
Investor Presentation May 2016 Pg.9 70 50% 45.4% 60 40% 50 31.0% 30% 40 28.8% 26.2% 30 58.7 Gearing ratio 22.0% 20% Net debt ($ millions) 17.7% NE T DE BT 20 A N D G E A RI N G 26.5 26.1 10% 25.3 10 18.9 13.4 0 0% 2011 2012 2013 2014 2015 2016 net debt gearing ratio (net debt)
Slide 11: Comvita Strategy
Investor Presentation May 2016 Pg.10 COMVITA STRATEGY $40 0 m by 20 20 EAR NING S SECU RITY INNOV ATIO N CONSU M ER- F OCU S ED AQU ISITIO NS F OCU S OF SUPPL Y B U SINESS M OD EL Concentrate on Continued Optimise and Increase market Focus on earnings earnings growth development diversify ingredient